A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Diabetic Retinopathy Without Center Involved-Diabetic Macular Edema
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Regenxbio, Inc.
Start Date
October 28, 2022
End Date
September 30, 2027
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Regenxbio, Inc.
Start Date
October 28, 2022
End Date
September 30, 2027